Opening the DOR on antidepressant effects

被引:89
作者
Jutkiewicz, Emily M. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1124/mi.6.3.7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the delta-opioid receptor (DOR) system produces an interesting behavioral profile distinct from that of other opioids. Unlike mu- and kappa-opioid agonists, delta-opioid agonists alone have limited pain-relieving qualities as measured in morphine-sensitive antinociceptive assays. Recent evidence, however, suggests that the DOR system may play a role in regulating mood and emotional states. For example, DOR activation stimulates robust antidepressant-like effects in preclinical assays, suggesting that these compounds may have therapeutic potential for treating human depression. This review discusses the role of the DORs in depression and the antidepressant-like effects of delta-opioid agonists as well as their limitations.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 68 条
[1]   ANTIDEPRESSANT-TYPE EFFECTS OF ENDOGENOUS ENKEPHALINS PROTECTED BY SYSTEMIC RB-101 ARE MEDIATED BY OPIOID-DELTA AND DOPAMINE-D1 RECEPTOR STIMULATION [J].
BAAMONDE, A ;
DAUGE, V ;
RUIZGAYO, M ;
FULGA, IG ;
TURCAUD, S ;
FOURNIEZALUSKI, MC ;
ROQUES, BP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 216 (02) :157-166
[2]   Recent progress in pharmacological and non-pharmacological treatment options of major depression [J].
Baghai, TC ;
Möller, HJ ;
Rupprecht, R .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (04) :503-515
[3]   Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm [J].
Besson, A ;
Privat, AM ;
Eschalier, A ;
Fialip, J .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 64 (03) :541-548
[4]   BUPRENORPHINE TREATMENT OF REFRACTORY DEPRESSION [J].
BODKIN, JA ;
ZORNBERG, GL ;
LUKAS, SE ;
COLE, JO .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) :49-57
[5]   Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons [J].
Borlongan, CV ;
Su, TP ;
Wang, Y .
NEUROREPORT, 2000, 11 (05) :923-926
[6]   Nonpeptidic δ-opioid receptor agonists reduce immobility in the forced swim assay in rats [J].
Broom, DC ;
Jutkiewicz, EM ;
Folk, JE ;
Traynor, JR ;
Rice, KC ;
Woods, JH .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (06) :744-755
[7]   Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats [J].
Broom, DC ;
Jutkiewicz, EM ;
Folk, JE ;
Traynor, JR ;
Rice, KC ;
Woods, JH .
PSYCHOPHARMACOLOGY, 2002, 164 (01) :42-48
[8]  
Catlin D H, 1980, Adv Biochem Psychopharmacol, V22, P465
[9]   ANALGESIC AND ACUTE CENTRAL-NERVOUS-SYSTEM SIDE-EFFECTS OF THE INTRAVENOUSLY ADMINISTERED ENKEPHALINASE INHIBITOR SCH-32615 [J].
CHIPKIN, RE ;
COFFIN, VL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (01) :21-27
[10]  
COMER SD, 1993, J PHARMACOL EXP THER, V267, P888